Ulf Schött

Professor

Lund University

Sweden

Research Interests

Explore related searches

Professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Ulf Schött is a Professor at Lund University in Sweden. His research focuses on vitamin K administration, coagulation processes, and the impact of direct oral anticoagulants in critically ill patients. Recent articles include studies on ROTEM® variables, biomarkers in hematological patients, and the effectiveness of intravenous Vitamin K1. He contributes significantly to the understanding of thromboprophylaxis and coagulation management in clinical settings.

Articles (12)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (2)

Owain Thomas

Lund University

SWEDEN

View details

Thomas Kander

Lund University

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ulf Schött

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Vitamin K1 Administration Increases the Level of Circulating Carboxylated Osteocalcin in Critically Ill Patients

Synergistic effects of rivaroxaban and hypothermia or acidosis on coagulation initiation measured with ROTEM ®

Impact of direct oral anticoagulants on ROTEM® variables; a sample size-calculated experimental study

Direct oral anticoagulants should often be suspended for longer before neuraxial blockade

The precision of ROTEM EXTEM is decreased in hypocoagulable blood

Biomarkers of complement and platelet activation are not correlated with the one or twenty-four hours corrected count increments in prophylactically platelet transfused hematological patients

Vitamin K Effects on Gas6 and Soluble Axl Receptors in Intensive Care Patients: An Observational Screening Study

Intravenous Vitamin K1 for the Correction of Prolonged Prothrombin Times in Non-Bleeding Critically Ill Patients: A Prospective Observational Study

Monitoring of Low Molecular Weight Heparin Thromboprophylaxis with Alternative Methods to Anti-Factor Xa

The effect of vitamin K on prothrombin time in critically ill patients: an observational registry study.

NOMI after cardiac arrest. Could refined diagnostics improve outcome?

Synergistic platelet inhibition between Omega-3 and acetylsalicylic acid dose titration; an observational study

Collaborators (2)

Owain Thomas

Thomas Kander

Make your next move.